The basis of current and future therapy for inflammatory bowel disease

被引：33

作者：

Elson, CO ^{[1
]}

机构：

[1] UNIV ALABAMA,DIV GASTROENTEROL & HEPATOL,BIRMINGHAM,AL

来源：

AMERICAN JOURNAL OF MEDICINE | 1996年 / 100卷 / 06期

关键词：

D O I：

10.1016/S0002-9343(96)00049-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This article describes current medical therapy as well as the types and theoretical basis of novel therapies now on the horizon for treating inflammatory bowel disease.

引用

页码：656 / 662

页数：7

共 26 条

[21]

PRESENT DH, 1989, GASTROENTEROL CLIN N, V18, P57

[22] ORAL MESALAMINE (ASACOL) FOR MILDLY TO MODERATELY ACTIVE ULCERATIVE-COLITIS - A MULTICENTER STUDY [J].

SNINSKY, CA ;

CORT, DH ;

SHANAHAN, F ;

POWERS, BJ ;

SESSIONS, JT ;

PRUITT, RE ;

JACOBS, WH ;

LO, SK ;

TARGAN, SR ;

CERDA, JJ ;

GREMILLION, DE ;

SNAPE, WJ ;

SABEL, J ;

JINICH, H ;

SWINEHART, JM ;

DEMICCO, MP .

ANNALS OF INTERNAL MEDICINE, 1991, 115 (05) :350-355

[23]

STROM TB, 1993, ANNU REV MED, V44, P343, DOI 10.1146/annurev.me.44.020193.002015

[24]

SUMMERS RW, 1979, GASTROENTEROLOGY, V77, P847

[25] 5-AMINOSALICYLIC ACID ENEMA IN THE TREATMENT OF DISTAL ULCERATIVE-COLITIS, PROCTOSIGMOIDITIS, AND PROCTITIS [J].

SUTHERLAND, LR ;

MARTIN, F ;

GREER, S ;

ROBINSON, M ;

GREENBERGER, N ;

SAIBIL, F ;

MARTIN, T ;

SPARR, J ;

PROKIPCHUK, E ;

BORGEN, L .

GASTROENTEROLOGY, 1987, 92 (06) :1894-1898

[26] TREATMENT OF CROHNS-DISEASE WITH ANTITUMOR NECROSIS FACTOR CHIMERIC MONOCLONAL-ANTIBODY (CA2) [J].

VANDULLEMEN, HM ;

VANDEVENTER, SJH ;

HOMMES, DW ;

BIJL, HA ;

JANSEN, J ;

TYTGAT, GNJ ;

WOODY, J .

GASTROENTEROLOGY, 1995, 109 (01) :129-135

← 1 2 3 →